Stanley Tennant, Director at Trovagene, Inc. (TROV), bought 10,000 shares at $2.10 ($21K) on 2016-12-19, disclosed to the SEC on 2016-12-19.
Open-market purchase of $21k TROV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TROV | BUY | 2016-12-19 | $30K | — | Filing → |
| TROV | BUY | 2015-08-12 | $61K | — | Filing → |
| TROV | BUY | 2012-12-03 | $121K | — | Filing → |